ArticleThe Journal of clinical investigation2022

Harnessing tumorous flaws for immune supremacy: is miRNA-155 the weak link in breast cancer progression?

Samantha Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.